Evidence map›Paper›PMID 40103402›Full record

ArticleBJS open2025

Regional patterns of early-onset colorectal cancer from the GEOCODE (Global Early-Onset COlorectal Cancer DatabasE)-European consortium: retrospective cohort study.

Maria Daca-Alvarez, José Perea, Luis Corchete, Antonino Spinelli, Caterina Foppa, Noel F C C de Miranda, Maartje Nielsen, Claire Palles, Helen M Curley, Marc Marti-Gallostra and 20 more

Abstract readMulticenter Study
In one paragraph

Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2025
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Maria Daca-AlvarezDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.ORCID 0000-0001-5636-8865
José PereaMolecular Medicine Unit-Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain.ORCID 0000-0001-5522-8844
Luis CorcheteMolecular Medicine Unit-Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain.ORCID 0000-0003-4577-8599
Antonino SpinelliDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID 0000-0002-1493-1768
Caterina FoppaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID 0000-0001-9920-0368
Noel F C C de MirandaDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Maartje NielsenDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0002-5351-1870
Claire PallesDepartment of Cancer and Genomic Sciences, Birmingham City University, Birmingham, West Midlands, UK.
Helen M CurleyDepartment of Cancer and Genomic Sciences, Birmingham City University, Birmingham, West Midlands, UK.
Marc Marti-GallostraDepartment of Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain.
Mireia VerdaguerDepartment of Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain.
Alfredo VivasDepartment of Surgery, Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain.
Sofia LorenzoDepartment of Surgery, Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain.
Andrew LatchfordDepartment of Gastroenterology, London Northwest Healthcare NHS Trust, Harrow, London, UK.
Omar FaizDepartment of Gastroenterology, London Northwest Healthcare NHS Trust, Harrow, London, UK.
Kevin MonahanDepartment of Surgery and Cancer, Imperial College, London, UK.
Nikhil PawaDepartment of Surgery, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Marek SzczepkowskiClinical Department of Colorectal, General and Oncological Surgery, Centre of Postgraduate Medical Education in Warsaw, Bielanski Hospital in Warsaw, Warsaw, Poland.
Bartosz ZiółkowskiClinical Department of Colorectal, General and Oncological Surgery, Centre of Postgraduate Medical Education in Warsaw, Bielanski Hospital in Warsaw, Warsaw, Poland.
Wieslaw TarnowskiDepartment of Surgery, Samodzielny Publiczny Szpital Kliniczny im prof Witolda Orrowskiego, Warszawa, Poland.
Mariusz UryszekDepartment of Surgery, Samodzielny Publiczny Szpital Kliniczny im prof Witolda Orrowskiego, Warszawa, Poland.
Silviu-Tiberiu Makkai-PopaDepartment of Surgery, Centre Hospitalier de Luxembourg Eich, Luxembourg, Luxembourg.
Juan S AzagraDepartment of Surgery, Centre Hospitalier de Luxembourg Eich, Luxembourg, Luxembourg.
Joan LlachDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Leticia MoreriaDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Maria PelliseDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Andreana N HolowatyjDepartment of Medicine, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.
Rogelio González-SarmientoMolecular Medicine Unit-Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain.
Francesc BalaguerDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
GEOCODE (Global Early-Onset Colorectal Cancer Database) consortium

Funding

European UnionInstituto de Salud Carlos IIISpanish Ministry of Health and Consumer Affairs and FEDER PI19/01867
6 · The paper itself

Abstract

backgroundThe incidence of early-onset colorectal cancer is increasing, but in Europe this growth shows a heterogeneous pattern in different countries and regions.

methodsPatients from six countries who participated in the Global Early-Onset COlorectal Cancer DatabasE (GEOCODE)-Europe group were included. The inclusion criteria were patients with colorectal adenocarcinoma diagnosed between 18 and 49 years of age, between January 2010 and December 2017, with at least 3 years of follow-up. Patients with inherited colorectal cancer syndromes were excluded.

resultsA total of 851 patients were included with almost equal sex distribution, most were diagnosed at age 39 years or older and 42% of patients were overweight or obese. Diagnoses were predominantly at later stages (62.5% stage III-IV) and tumours were predominantly located in the distal colon (76.9% left colon and rectum). Comparative analysis between countries demonstrated that the UK had a younger age at diagnosis and the Italian cohort had a higher prevalence of being overweight or obese. Patients from Luxembourg had more advanced stage diagnoses and those from The Netherlands had more polyps. Patients from the UK had a greater family history of colorectal cancer. Comparison of Mediterranean versus non-Mediterranean countries showed significant differences in the age at diagnosis and body mass index. The prevalence of early-onset colorectal cancer over the age of 40 years in Mediterranean versus non-Mediterranean countries was 71.4% versus 62.1% (P = 0.002), and early-onset colorectal cancer was diagnosed at a more advanced stage in Mediterranean countries versus non-Mediterranean countries (65.3% versus 54.7%; P = 0.033). Family history of colorectal cancer in a first-degree relative was more common in non-Mediterranean versus Mediterranean countries (19.1% versus 11.4%; P < 0.001).

conclusionThis study highlights significant geographical disparities in the clinical, pathological and familial features of early-onset colorectal cancer across European countries.

Indexed as

AdenocarcinomaColorectal NeoplasmsAdolescentAdultAge of OnsetBody Mass IndexDatabases, FactualEuropeFemaleHumansIncidenceMaleMiddle AgedNeoplasm StagingObesityOverweight

Identifiers

PMID40103402
PMCPMC11920508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.